Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-03-09 @ 4:28 AM
Study NCT ID:
NCT03744793
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-30
First Post:
2018-11-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant | View |
| None | Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation | View |
| None | Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation | View |
| None | Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant | View |
| None | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | View |
| None | Metastatic Urothelial Carcinoma | View |
| None | MTAP Negative | View |
Keywords: